Literature DB >> 28398740

Structural Reassignment and Absolute Stereochemistry of Madurastatin C1 (MBJ-0034) and the Related Aziridine Siderophores: Madurastatins A1, B1, and MBJ-0035.

Andrew R Tyler, Hamed Mosaei, Stephanie Morton, Paul G Waddell, Corinne Wills, William McFarlane, Joe Gray, Michael Goodfellow, Jeff Errington1, Nick Allenby1, Nikolay Zenkin, Michael J Hall.   

Abstract

The madurastatins are pentapeptide siderophores originally described as containing an unusual salicylate-capped N-terminal aziridine ring. Isolation of madurastatin C1 (1) (also designated MBJ-0034), from Actinomadura sp. DEM31376 (itself isolated from a deep sea sediment), prompted structural reevaluation of the madurastatin siderophores, in line with the recent work of Thorson and Shaaban. NMR spectroscopy in combination with partial synthesis allowed confirmation of the structure of madurastatin C1 (1) as containing an N-terminal 2-(2-hydroxyphenyl)oxazoline in place of the originally postulated aziridine, while absolute stereochemistry was determined via Harada's advanced Marfey's method. Therefore, this work further supports Thorson and Shaaban's proposed structural revision of the madurastatin class of siderophores (madurastatins A1 (2), B1 (3), C1 (1), and MBJ-0036 (4)) as N-terminal 2-(2-hydroxyphenyl)oxazolines.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28398740      PMCID: PMC6544507          DOI: 10.1021/acs.jnatprod.7b00082

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  31 in total

1.  Reductive deprotection of N-tritylaziridines.

Authors:  E Vedejs; A Klapars; D L Warner; A H Weiss
Journal:  J Org Chem       Date:  2001-11-02       Impact factor: 4.354

2.  Diversity of cultivable actinobacteria in geographically widespread marine sediments.

Authors:  Luis A Maldonado; James E M Stach; Wasu Pathom-aree; Alan C Ward; Alan T Bull; Michael Goodfellow
Journal:  Antonie Van Leeuwenhoek       Date:  2005-01       Impact factor: 2.271

3.  Brasilibactin A, a cytotoxic compound from actinomycete Nocardia brasiliensis.

Authors:  Masashi Tsuda; Masaaki Yamakawa; Seiko Oka; Yasushi Tanaka; Yasutake Hoshino; Yuzuru Mikami; Ayumi Sato; Hironori Fujiwara; Yasushi Ohizumi; Jun'ichi Kobayashi
Journal:  J Nat Prod       Date:  2005-03       Impact factor: 4.050

4.  Transvalencin Z, a new antimicrobial compound with salicylic acid residue from Nocardia transvalensis IFM 10065.

Authors:  Akira Mukai; Toshio Fukai; Yuko Matsumoto; Jun Ishikawa; Yasutaka Hoshino; Katsukiyo Yazawa; Ken-ichi Harada; Yuzuru Mikami
Journal:  J Antibiot (Tokyo)       Date:  2006-06       Impact factor: 2.649

Review 5.  Siderophore-based iron acquisition and pathogen control.

Authors:  Marcus Miethke; Mohamed A Marahiel
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

6.  Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. Part 3: Chemical derivatization.

Authors:  Riccardo Mariani; Giorgio Granata; Sonia I Maffioli; Stefania Serina; Cristina Brunati; Margherita Sosio; Alessandra Marazzi; Alfredo Vannini; Dinesh Patel; Richard White; Romeo Ciabatti
Journal:  Bioorg Med Chem Lett       Date:  2005-08-15       Impact factor: 2.823

7.  Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor.

Authors:  A J Phillips; Y Uto; P Wipf; M J Reno; D R Williams
Journal:  Org Lett       Date:  2000-04-20       Impact factor: 6.005

8.  Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. II. Structure elucidation.

Authors:  Alessandra Marazzi; Michael Kurz; Stefania Stefanelli; Luigi Colombo
Journal:  J Antibiot (Tokyo)       Date:  2005-04       Impact factor: 2.649

9.  Isolation and structural characterization of siderophores, madurastatins, produced by a pathogenic Actinomadura madurae.

Authors:  Ken-ichi Harada; Koji Tomita; Kiyonaga Fujii; Katsuyoshi Masuda; Yuzuru Mikami; Katsukiyo Yazawa; Hisayuki Komaki
Journal:  J Antibiot (Tokyo)       Date:  2004-02       Impact factor: 2.649

10.  Nocardichelins A and B, siderophores from Nocardia strain acta 3026.

Authors:  Kathrin Schneider; Ilona Rose; Sabaratnam Vikineswary; Amanda L Jones; Michael Goodfellow; Graeme Nicholson; Winfried Beil; Roderich D Süssmuth; Hans-Peter Fiedler
Journal:  J Nat Prod       Date:  2007-05-31       Impact factor: 4.050

View more
  5 in total

Review 1.  Recent trends in the structural revision of natural products.

Authors:  Bhuwan Khatri Chhetri; Serge Lavoie; Anne Marie Sweeney-Jones; Julia Kubanek
Journal:  Nat Prod Rep       Date:  2018-06-20       Impact factor: 13.423

2.  Genome Mining and Metabolomics Unveil Pseudonochelin: A Siderophore Containing 5-Aminosalicylate from a Marine-Derived Pseudonocardia sp. Bacterium.

Authors:  Fan Zhang; René F Ramos Alvarenga; Kurt Throckmorton; Shaurya Chanana; Doug R Braun; Jen Fossen; Miao Zhao; Sue McCrone; Mary Kay Harper; Scott R Rajski; Warren E Rose; David R Andes; Michael G Thomas; Tim S Bugni
Journal:  Org Lett       Date:  2022-06-01       Impact factor: 6.072

3.  Madurastatin D1 and D2, Oxazoline Containing Siderophores Isolated from an Actinomadura sp.

Authors:  Jia-Xuan Yan; Marc G Chevrette; Doug R Braun; Mary Kay Harper; Cameron R Currie; Tim S Bugni
Journal:  Org Lett       Date:  2019-08-05       Impact factor: 6.005

4.  Establishment of a Charge Reversal Derivatization Strategy to Improve the Ionization Efficiency of Limaprost and Investigation of the Fragmentation Patterns of Limaprost Derivatives Via Exclusive Neutral Loss and Survival Yield Method.

Authors:  Dong Sun; Xiangjun Meng; Tianming Ren; John Paul Fawcett; Hualu Wang; Jingkai Gu
Journal:  J Am Soc Mass Spectrom       Date:  2018-04-09       Impact factor: 3.109

5.  GNPS-Guided Discovery of Madurastatin Siderophores from the Termite-Associated Actinomadura sp. RB99.

Authors:  Seoung Rak Lee; Felix Schalk; Jan W Schwitalla; Huijuan Guo; Jae Sik Yu; Moonyong Song; Won Hee Jung; Z Wilhelm de Beer; Christine Beemelmanns; Ki Hyun Kim
Journal:  Chemistry       Date:  2022-05-19       Impact factor: 5.020

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.